1. Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research. 2019; 12:1-14.
4. Francescangeli J, Karamchandani K, et al. The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice. International Journal of Molecular Sciences. 2019; 20, 2288.
5. FDA. FDA Drug Safety Communication: FDA warns about several safety issues with opioid pain medicines; requires label changes. 2016. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-several-safety-issues-opioid-pain-medicines-requires
6. Foong AL, Grindod KA, et al. Demystifying serotonin syndrome (or serotonin toxicity). Canadian Family Physician. 2018; 64: 720-727.